National Yang Ming Chiao Tung University

Shared MHC class II neoantigen design for breast cancer, pairing retrieval-augmented ProtT5 embeddings with an MCNN-BiLSTM immunogenicity classifier.

SMILES generative model for de novo drug design, pretrained on 200 million ZINC20 compounds with a tokenizer built from frequent substructures.